Welcome to VERCIDA website.

Skip to main content
Enable Recite to make this website accessible

GSK creates 150 new jobs in Ware, UK

Category: Industry News

Image of an icon of human lungs
  • Opening creates 150 jobs; more than 400 created at the site since 2013
  • Facility needed to meet growing export demand for GSK respiratory medicines

GSK today opens a £56 million state of the art manufacturing facility, creating 150 new jobs in the UK, in response to demand for GSK’s portfolio of respiratory medicines delivered by the innovative Ellipta inhaler.

The new 4500m2 facility will be opened by UK Life Sciences Minister George Freeman MP and GSK Chief Executive Officer Sir Andrew Witty. It is the latest expansion for Ellipta manufacturing at Ware, with investment totalling over £100 million over the past five years. The new facility opening today is expected to nearly double production of Ellipta inhalers at Ware to at least 37 million per year by 2017, 95% of which will be exported.

Since 2013, over 400 additional roles will have been created at the manufacturing site in Ware, bringing staff numbers to more than 1200. This includes over 30 apprentice and 50 graduate roles as part of GSK’s commitment to creating highly skilled roles for young people.

Sir Andrew Witty, CEO, GSK said, “This new facility demonstrates our commitment to manufacturing in the UK which continues to be a very positive environment for life sciences investment. We have been leaders in respiratory since the 1960s when we first began making inhalers for the treatment of respiratory diseases in Ware and it continues to be a critically important site for us, both in terms of researching and developing innovative new inhaler technology, and as a world-leading manufacturing hub. We currently export Ellipta inhalers from Ware to over 74 countries and the new facility opened today will increase capacity to meet growing demand for our new portfolio of respiratory medicines worldwide.”

Life Sciences Minister George Freeman MP said, “This £56 million investment by GSK is fantastic news for Ware and the UK’s thriving life sciences industry. As well as driving growth and creating 150 new jobs, this expansion of GSK's medicines manufacturing facility in Ware is a strong endorsement of the UK's leadership in manufacturing and respiratory medicine."

Are you interested in a career with GSK? Please click here!

VERCIDA works with over one hundred clients who are committed to creating an inclusive work environment. If you are an employer and interested in working with VERCIDA to promote your diversity and inclusion initiatives and attract the best candidates, please call 02037405973 or email info@vercida.com for more information.

We are also officially recommended by Disability Confident as a step on achieving Employer status, please click here for more information.

Vercida logo

VERCIDA works with over one hundred clients who are committed to creating an inclusive work environment. If you are an employer and interested in working with VERCIDA to promote your diversity and inclusion initiatives and attract the best candidates, please email info@vercida.com for more information.

Learn more about this employer

GlaxoSmithKline

Inclusive features

  • No matching inclusive features

Section with Articles you might like

See all articles

You will receive an email with link to reset your password.

Enter your new password